A multicentre randomised clinical endpoint study of parma 5 computer-assisted oral anticoagulant dosage

Leon Poller, Michelle Keown, Saied Ibrahim, Gordon Lowe, Marco Moia, Alexander G. Turpie, Christopher Roberts, Aton M H P Van Den Besselaar, Felix J M Van Der Meer, Armando Tripodi, Gualtiero Palareti, Jørgen Jespersen

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

To meet growing demand for oral anticoagulation worldwide there has been increased dependence on computer-assistance in dosage although the safety and effectiveness of any of the individual computer-assisted dosage programs has not previously been established. This randomised multicentre clinical end-point study assessed a new version of the parma 5 program. It compared parma 5 safety and effectiveness with manual dosage by experienced medical staff at 19 centres with a known interest in oral anticoagulation. Target recruitment was 8000 patient-years, randomised to medical staff or parma-5 assisted dosage. Safety and effectiveness of the parma 5 program was compared with manual dosage. A total of 10 421 patients were recruited (15 369 patient-years) in the 5-year study. International normalised ratio (INR) tests numbered 167 791 with manual and 160 078 with parma 5 dosage. With parma 5 there was overall a non-significant reduction in clinical events but in the 2542 patients with deep vein thrombosis/pulmonary embolism, clinical events were significantly reduced (P = 0.005). Success in achieving 'time in target INR range' was also significantly greater with parma 5 compared with the dosage by experienced medical staff. This study demonstrated the safety and effectiveness of parma 5-assisted dosage.

Original languageEnglish
Pages (from-to)274-283
Number of pages10
JournalBritish Journal of Haematology
Volume143
Issue number2
DOIs
Publication statusPublished - Oct 2008

Fingerprint

Anticoagulants
Medical Staff
Safety
International Normalized Ratio
Pulmonary Embolism
Venous Thrombosis
Clinical Studies

Keywords

  • Clinical events
  • Computer dosage
  • International normalised ratio
  • Safety and effectiveness
  • Time-in-range

ASJC Scopus subject areas

  • Hematology

Cite this

A multicentre randomised clinical endpoint study of parma 5 computer-assisted oral anticoagulant dosage. / Poller, Leon; Keown, Michelle; Ibrahim, Saied; Lowe, Gordon; Moia, Marco; Turpie, Alexander G.; Roberts, Christopher; Van Den Besselaar, Aton M H P; Van Der Meer, Felix J M; Tripodi, Armando; Palareti, Gualtiero; Jespersen, Jørgen.

In: British Journal of Haematology, Vol. 143, No. 2, 10.2008, p. 274-283.

Research output: Contribution to journalArticle

Poller, L, Keown, M, Ibrahim, S, Lowe, G, Moia, M, Turpie, AG, Roberts, C, Van Den Besselaar, AMHP, Van Der Meer, FJM, Tripodi, A, Palareti, G & Jespersen, J 2008, 'A multicentre randomised clinical endpoint study of parma 5 computer-assisted oral anticoagulant dosage', British Journal of Haematology, vol. 143, no. 2, pp. 274-283. https://doi.org/10.1111/j.1365-2141.2008.07337.x
Poller, Leon ; Keown, Michelle ; Ibrahim, Saied ; Lowe, Gordon ; Moia, Marco ; Turpie, Alexander G. ; Roberts, Christopher ; Van Den Besselaar, Aton M H P ; Van Der Meer, Felix J M ; Tripodi, Armando ; Palareti, Gualtiero ; Jespersen, Jørgen. / A multicentre randomised clinical endpoint study of parma 5 computer-assisted oral anticoagulant dosage. In: British Journal of Haematology. 2008 ; Vol. 143, No. 2. pp. 274-283.
@article{1c0de954a52346349fce0f815d63f746,
title = "A multicentre randomised clinical endpoint study of parma 5 computer-assisted oral anticoagulant dosage",
abstract = "To meet growing demand for oral anticoagulation worldwide there has been increased dependence on computer-assistance in dosage although the safety and effectiveness of any of the individual computer-assisted dosage programs has not previously been established. This randomised multicentre clinical end-point study assessed a new version of the parma 5 program. It compared parma 5 safety and effectiveness with manual dosage by experienced medical staff at 19 centres with a known interest in oral anticoagulation. Target recruitment was 8000 patient-years, randomised to medical staff or parma-5 assisted dosage. Safety and effectiveness of the parma 5 program was compared with manual dosage. A total of 10 421 patients were recruited (15 369 patient-years) in the 5-year study. International normalised ratio (INR) tests numbered 167 791 with manual and 160 078 with parma 5 dosage. With parma 5 there was overall a non-significant reduction in clinical events but in the 2542 patients with deep vein thrombosis/pulmonary embolism, clinical events were significantly reduced (P = 0.005). Success in achieving 'time in target INR range' was also significantly greater with parma 5 compared with the dosage by experienced medical staff. This study demonstrated the safety and effectiveness of parma 5-assisted dosage.",
keywords = "Clinical events, Computer dosage, International normalised ratio, Safety and effectiveness, Time-in-range",
author = "Leon Poller and Michelle Keown and Saied Ibrahim and Gordon Lowe and Marco Moia and Turpie, {Alexander G.} and Christopher Roberts and {Van Den Besselaar}, {Aton M H P} and {Van Der Meer}, {Felix J M} and Armando Tripodi and Gualtiero Palareti and J{\o}rgen Jespersen",
year = "2008",
month = "10",
doi = "10.1111/j.1365-2141.2008.07337.x",
language = "English",
volume = "143",
pages = "274--283",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "John Wiley & Sons, Ltd (10.1111)",
number = "2",

}

TY - JOUR

T1 - A multicentre randomised clinical endpoint study of parma 5 computer-assisted oral anticoagulant dosage

AU - Poller, Leon

AU - Keown, Michelle

AU - Ibrahim, Saied

AU - Lowe, Gordon

AU - Moia, Marco

AU - Turpie, Alexander G.

AU - Roberts, Christopher

AU - Van Den Besselaar, Aton M H P

AU - Van Der Meer, Felix J M

AU - Tripodi, Armando

AU - Palareti, Gualtiero

AU - Jespersen, Jørgen

PY - 2008/10

Y1 - 2008/10

N2 - To meet growing demand for oral anticoagulation worldwide there has been increased dependence on computer-assistance in dosage although the safety and effectiveness of any of the individual computer-assisted dosage programs has not previously been established. This randomised multicentre clinical end-point study assessed a new version of the parma 5 program. It compared parma 5 safety and effectiveness with manual dosage by experienced medical staff at 19 centres with a known interest in oral anticoagulation. Target recruitment was 8000 patient-years, randomised to medical staff or parma-5 assisted dosage. Safety and effectiveness of the parma 5 program was compared with manual dosage. A total of 10 421 patients were recruited (15 369 patient-years) in the 5-year study. International normalised ratio (INR) tests numbered 167 791 with manual and 160 078 with parma 5 dosage. With parma 5 there was overall a non-significant reduction in clinical events but in the 2542 patients with deep vein thrombosis/pulmonary embolism, clinical events were significantly reduced (P = 0.005). Success in achieving 'time in target INR range' was also significantly greater with parma 5 compared with the dosage by experienced medical staff. This study demonstrated the safety and effectiveness of parma 5-assisted dosage.

AB - To meet growing demand for oral anticoagulation worldwide there has been increased dependence on computer-assistance in dosage although the safety and effectiveness of any of the individual computer-assisted dosage programs has not previously been established. This randomised multicentre clinical end-point study assessed a new version of the parma 5 program. It compared parma 5 safety and effectiveness with manual dosage by experienced medical staff at 19 centres with a known interest in oral anticoagulation. Target recruitment was 8000 patient-years, randomised to medical staff or parma-5 assisted dosage. Safety and effectiveness of the parma 5 program was compared with manual dosage. A total of 10 421 patients were recruited (15 369 patient-years) in the 5-year study. International normalised ratio (INR) tests numbered 167 791 with manual and 160 078 with parma 5 dosage. With parma 5 there was overall a non-significant reduction in clinical events but in the 2542 patients with deep vein thrombosis/pulmonary embolism, clinical events were significantly reduced (P = 0.005). Success in achieving 'time in target INR range' was also significantly greater with parma 5 compared with the dosage by experienced medical staff. This study demonstrated the safety and effectiveness of parma 5-assisted dosage.

KW - Clinical events

KW - Computer dosage

KW - International normalised ratio

KW - Safety and effectiveness

KW - Time-in-range

UR - http://www.scopus.com/inward/record.url?scp=52649142040&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=52649142040&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2141.2008.07337.x

DO - 10.1111/j.1365-2141.2008.07337.x

M3 - Article

VL - 143

SP - 274

EP - 283

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 2

ER -